Key facts
- InHome Therapy’s last known valuation is $60.1M.
- It has raised $30.8M; the latest was Early Stage VC ($5.1M) in May 2024.
- Notable investors include NewSpring Capital, Altos Health, TT Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for InHome Therapy
- ·The full record, as it builds
Funding rounds
No funding rounds for InHome Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InHome Therapy
Provider of at-home-based therapy and rehabilitation services intended to transform home healthcare alternatives. The company provides various physical, occupational, and speech therapists for patients with different medical conditions, enabling patients to rehabilitate at home with safety and comfort.
- Sector
- Healthcare
- HQ
- King of Prussia, PA, United States
- Founded
- 2021
- Employees
- 148
- Website
- inhometherapy.com/
- Ownership
- Privately Held (backing)
InHome Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InHome Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InHome Therapy in its N-PORT filings yet. We sweep new filings monthly.